Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

By sjmartinez • January 29, 2025

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA. Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093/cid/ciae648. Epub ahead of print. PMID: 39873495.

Tags: antiretroviral agents, Cabotegravir, Health policy, Infectious Diseases, lenacapavir, Pre-exposure prophylaxis, Publications

Bispecific antibodies cross-link and redirect CD8+ T cells to kill cytomegalovirus-infected cells

Ali A, Balamurugan A, Ibarrondo FJ, Nguyen M, Habibipour S, Lim JM, Hofmann C, Ng HL, Yang OO. Bispecific antibodies cross-link and redirect CD8+ T cells[...]

Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium

Zaman F, Zhu X, Hunt JH, Rozek G, Eby Y, Hussain S, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock[...]

The life cycle of infection prevention and antimicrobial stewardship projects and interventions: the dynamic interplay of implementation and de-implementation science (Part I of II)

Branch-Elliman W, Chambers DA, Albin O, Batshon L, Castejon-Ramirez S, Cheng VC, Emetuche N, Datta R, Kamboj M, Krein SL, Staub M, Dassum SR, Rittmann[...]